Corcept Therapeutics Inc. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Corcept Therapeutics Inc.

Sort by

Viewing results 1‒25 of 388

News in-depthPfizer Inc
Covid vaccine winners suffer reversal of fortune
...The New York-based pharma group has acquired four companies — Arena, ReViral, Biohaven and Global Blood Therapeutics — that it expects will contribute about $10bn in revenues in 2030....
October 3, 2023
Medical science
UK approves Crispr gene editing therapy in global first
...The Medicines and Healthcare products Regulatory Agency has approved the therapy, called Casgevy, which was developed by Vertex Pharmaceuticals and Crispr Therapeutics....
November 16, 2023
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
LexPfizer Inc
Pfizer: pharma group needs weight loss drug to secure post-Covid future Premium content
...It acquired obesity drug developer Carmot Therapeutics for $2.7bn....
December 13, 2023
Coronavirus treatment
Covid antivirals lose spark as regulatory scrutiny increases
...molnupiravir or Paxlovid will [still] be effective, now that most people have been either vaccinated or infected,” said Andy Hill, a senior visiting research fellow at Liverpool university’s pharmacology and therapeutics...
October 9, 2023
Due Diligence
Could the ‘trustbusters’ be making a comeback?
...to rescue Farfetch Regulators even out the antitrust score Global regulators had been on a losing streak lately, with back-to-back losses including Amgen’s $28bn takeover of fellow drugmaker Horizon Therapeutics...
December 19, 2023
LexMergers & Acquisitions
Pharma: M&A strategy gets dose of bitter medicine Premium content
...Monday’s acquisition by Novartis of Seattle-based biotech firm Chinook Therapeutics for up to $3.5bn is a case in point....
June 12, 2023
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
Amgen Inc
Regeneron boss backs attempt to block $28bn Amgen acquisition
...The Regeneron chief executive has backed an attempt by US regulators to block Amgen’s $28bn acquisition of Horizon Therapeutics as he accused some pharmaceutical companies of abusing their market power to...
May 17, 2023
Pfizer Inc
Pfizer to buy biotech group Biohaven for $11.6bn
...Pfizer spent $6.7bn on Arena Pharmaceuticals in December, lured by its medicines for immune-inflammatory diseases, and paid $2.3bn in August last year for Trillium Therapeutics as it targeted treatments...
May 10, 2022
Coronavirus treatment
Covid antiviral drug linked to ‘transmissible’ mutations, research finds
...Andrew Hill, a senior visiting research fellow at Liverpool university’s pharmacology and therapeutics department, said the drug also had potential side effects for pregnant women....
September 25, 2023
Virtual and Augmented Reality
Apple’s Vision Pro headset attracts investors back to lacklustre sector
...Massachusetts-based Luminopia, which creates therapeutic visual stimuli, raised $16mn in late June....
July 26, 2023
Amgen Inc
FTC warns of ‘rampant’ pharma consolidation as it targets $28bn Amgen deal
...regulators have warned that “rampant consolidation” in the pharmaceuticals industry is pushing up prices for patients as the Federal Trade Commission sued to block Amgen’s $28.3bn deal to acquire Horizon Therapeutics...
May 16, 2023
Amgen Inc
Amgen resolves US regulator’s challenge to $28bn Horizon deal
...Amgen has reached an agreement with the US antitrust regulator that allows the drugmaker to press ahead with its $28bn acquisition of Horizon Therapeutics....
September 1, 2023
On Wall StreetJames Fontanella-Khan
Banker glee does not tell the whole story on Lina Khan setbacks
...Khan has become such an antagonist for dealmakers and why they were rejoicing this month when Amgen reached a settlement with her agency, allowing the pharmaceutical company’s $28bn acquisition of Horizon Therapeutics...
September 9, 2023
FT News Briefing podcast10 min listen
US sues to block drug merger
...The Federal Trade Commission sued to block the biotechnology company Amgen’s $28.3bn deal to acquire Horizon Therapeutics, Italy is struggling to spend €200bn in EU Covid recovery funds, and Ukraine said...
May 17, 2023
Mergers & Acquisitions
M&A crackdown a ‘disaster’ for pharma sector, Pfizer executive warns
...His comments came after the US Federal Trade Commission on Tuesday sued to block Amgen’s $28bn takeover of Horizon Therapeutics....
May 17, 2023
FT Live
Due Diligence Live
Where leaders in investment and finance meet
Tuesday, 8 OctoberLondon, UK
LexHealth
Amgen/FTC: deal bar ignores realities of pharma food chain Premium content
...In December, biopharmaceutical firm Amgen announced the acquisition of biotech star Horizon Therapeutics for $116.50 per share or $28bn in aggregate....
May 17, 2023
Health
Amgen close to deal to buy Horizon Therapeutics for $20bn
...Amgen is close to a deal to acquire Horizon Therapeutics in a transaction worth as much as $20bn, according to sources familiar with the matter, as a sell-off in healthcare stocks creates attractive targets...
December 11, 2022
Biotech
Amgen to buy Horizon Therapeutics for $28.3bn
...Amgen has agreed to buy Horizon Therapeutics for $28.3bn, including debt, after the California-based biotech won a three-way race to secure a new pipeline of drugs for rare autoimmune and inflammatory diseases...
December 12, 2022
LexElaine Moore
The Lex Newsletter: Reddit and the API apocalypse Premium content
...The FTC attempted to block Amgen’s $28.3bn takeover of Horizon Therapeutics. Barriers to M&A are going to make it harder for pharma companies to replenish drug pipelines....
June 16, 2023
LexMerck & Co Inc
Merck/Prometheus: Big Pharma must swallow bigger premiums Premium content
...Late last year, Amgen bought Horizon Therapeutics for $28bn. Biotech and life science valuations have moderated since 2021. But the chance for premium buyouts has not disappeared....
April 17, 2023
Due Diligence
Microsoft races for UK compromise to seal Activision deal Premium content
...US Department of Justice, intend to follow through on their mission to draw a tougher line on antitrust.Still outstanding are large contested deals, including Amgen’s planned $28bn takeover of Horizon Therapeutics...
July 12, 2023
Japanese business & finance
Japan’s Astellas to buy US biotech group Iveric Bio for $5.9bn
...Astellas, Japan’s second-largest pharmaceutical company by revenue, has spent more than ¥1tn ($7.3bn) in overseas acquisitions and partnerships since 2007, including its $3bn purchase of US drugmaker Audentes Therapeutics...
May 1, 2023
Pfizer Inc
Pfizer to buy oncology-focused biotech Seagen for $43bn
...The deal follows Amgen’s $28.3bn acquisition of the Californian biotech Horizon Therapeutics in December. In 2023, Seagen expects revenue of about $2.2bn, a 12 per cent rise year on year....
March 13, 2023
John Gapper
A global antitrust alliance battles Microsoft and Amgen
...As the EU approved Microsoft’s $75bn bid to buy Activision Blizzard, the US Federal Trade Commission sued to block Amgen’s $28.3bn deal to acquire Horizon Therapeutics and warned of “rampant consolidation...
May 19, 2023
Due Diligence
What comes next for Microsoft’s $75bn Activision Blizzard deal? Premium content
...It’s litigating an order for Illumina to divest cancer screening company Grail in a vertical merger case and has also sued to block Amgen’s $28bn takeover of Horizon Therapeutics....
July 13, 2023

Previous pagePage 1 of 16Next page